Pathstone Family Office’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.61M Buy
6,520
+4,648
+248% +$1.27M 0.01% 523
2023
Q2
$717K Sell
1,872
-54
-3% -$15K 0.01% 599
2023
Q1
$511K Sell
1,926
-12,312
-86% -$3.13M 0.01% 687
2022
Q4
$2.27M Buy
14,238
+5,880
+70% +$1.32M 0.02% 471
2022
Q3
$1.54M Buy
+8,358
New +$1.67M 0.01% 536
2022
Q2
Sell
-1,313
Closed -$333K 1095
2022
Q1
$333K Buy
1,313
+103
+9% +$25.9K 0.01% 706
2021
Q4
$312K Buy
1,210
+377
+45% +$92.3K 0.01% 698
2021
Q3
$202K Buy
+833
New +$204K 0.01% 816
2021
Q1
Sell
-275
Closed -$46K 950
2020
Q4
$46K Buy
275
+1
+0.4% +$146 ﹤0.01% 529
2020
Q3
$34K Buy
+274
New +$33.9K ﹤0.01% 408
2017
Q2
Sell
-5
Closed 493
2017
Q1
$0 Buy
+5
New +$417 ﹤0.01% 593

Other funds holding HCA

Pathstone Family Office's HCA Position: Q3 2023 in Review

Pathstone Family Office increased its HCA Healthcare (HCA) stake by 248% in Q3 2023, buying an estimated $1.27M and bringing the position to 6,520 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #523.

Pathstone Family Office first reported a position in HCA in Q1 2017 and has held it in 11 quarters since. The position peaked at $2.27M in Q4 2022. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Pathstone Family Office held 6,520 shares of HCA Healthcare worth $1.61M as of Q3 2023.
  • Pathstone Family Office bought 4,648 HCA Healthcare shares in Q3 2023, an estimated $1.27M.
  • HCA Healthcare made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #523 holding.
  • Pathstone Family Office first reported a position in HCA Healthcare in Q1 2017 and has held it in 11 quarters since.
  • Pathstone Family Office's HCA Healthcare position peaked at $2.27M in Q4 2022.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.